Retinal layer thickness linked to cognitive decline in older adults
May 27, 2022
Thinner baseline total macular retinal nerve fiber layer thickness was associated with a larger decline in cognitive function test scores during follow-up.
Medicare spending would increase $2.0 to $5.1 billion with lecanemab
May 18, 2023
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
Assisted living memory care admission reduces odds of SNF placement, acute care stays, study finds
By
Alicia Lasek
Jan 07, 2022
Older adults living with dementia who move into memory care units in assisted living communities are less likely to experience a skilled nursing facility or a hospital stay than their peers who move into...
Physicians less likely to test for pulmonary embolism in dementia patients
Oct 01, 2021
The findings were seen in patients with dementia presenting with clinical factors known to be predictive of pulmonary embolism risk.
Higher triglyceride levels linked to lower dementia risk
Oct 26, 2023
Similar findings were seen in a a subcohort of participants with APOE-ε4 genetic data and in an external validation cohort.
You’ll never find a better investment opportunity than this
By
John O'Connor
Jun 15, 2017
An event happening next week is worthy of your most valuable asset — your time.
All types of visual impairment linked to dementia prevalence
Jul 14, 2023
Dementia prevalence was higher among those with near visual impairment, contrast sensitivity impairment and moderate or worse distance visual impairment.
Study identifies factors that predict driving cessation in seniors
May 22, 2024
Older age, female sex and progression to symptomatic Alzheimer’s disease were associated with driving cessation.
Alzheimer’s Association asks CMS to provide full coverage of FDA-approved dementia drugs
By
Kimberly Bonvissuto
Dec 21, 2022
Every day, more than 2,000 older adults living with mild dementia may transition to a more advanced stage of the disease and no longer be eligible for lecanemab and other antibodies targeting amyloid under...
‘Better business model’ needed for dementia care, Senate committee hears
By
Lois A. Bowers
Nov 21, 2019
A “better business model for the diagnosis and care of persons with Alzheimer’s disease” needs to be created, Jason Karlawish, M.D., said Wednesday at a Senate Finance Committee Subcommittee on Health...